SCHEMBL12600786

SCHEMBL12600786

CSC(C)(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL8037367 0.70
Hydrochloric Acid SCHEMBL8033568 0.70
SCHEMBL14580320 0.70
SCHEMBL11783445 0.70
SCHEMBL152843 0.67
SCHEMBL18335409 0.67
SCHEMBL14103800 0.67
SCHEMBL19688781 0.67
SCHEMBL23919427 0.65
SCHEMBL21566235 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017049316-A1 ASSOCIATIVE POLYMERS TO CONTROL FORMATION OF PARTICULATE MATTER FROM IGNITABLE COMPOSITIONS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-03-23 WO disclosed
EP-1730142-B1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORP (US) 2011-06-29 EP disclosed
EP-1737881-B1 NOVEL COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORP (US) 2009-06-24 EP disclosed
EP-1343807-B1 DIARYL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITS C VIRUS SCHERING CORP (US) 2009-04-29 EP disclosed
EP-1939213-A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-02 EP disclosed